Press release
2025 Metastatic Cancer Drugs Industry Trends Report: Long-Term Outlook Through 2034
Metastatic Cancer Drugs Market
How Large Will the Metastatic Cancer Drugs Market Size By 2025?
The market size for drugs treating metastatic cancer has been on a consistent rise in the past years. It's projected to increase from $58.07 billion in 2024 to $60.18 billion in 2025, achieving a compound annual growth rate (CAGR) of 3.6%. This growth during the past era has been fuelled by the advancement in chemotherapy, breakthroughs in targeted therapies, the emergence of immunotherapy, triumphs in clinical trials, and enhancement in diagnosis and staging procedures.
How Big Is the Metastatic Cancer Drugs Market Size Expected to Grow by 2029?
Anticipated robust growth in the approaching years is anticipated for the market of metastatic cancer drugs. Projections indicate an expansion up to "$74.71 billion in 2029", propelled by a compound annual growth rate (CAGR) of 5.6%. Factors such as the development of precision medicine, progress in biomarker-driven treatments, advancements in liquid biopsy, patient-focused methodologies, and all-encompassing genomic profiling contribute to the growth forecasted. Additionally, forthcoming trends include emerging combination treatments, progress in nanomedicine, enhanced support for long-term survivors, early intervention tactics, as well as health equity and access improvements.
View the full report here:
https://www.thebusinessresearchcompany.com/report/metastatic-cancer-drugs-global-market-report
Which Key Market Drivers Powering Metastatic Cancer Drugs Market Expansion and Growth?
The rising incidence of metastatic cancers, an advanced stage of cancer that spreads to other parts of the body, is anticipated to fuel the expansion of the metastatic cancer drugs market. As the number of metastatic cancer cases surges, it leads to the creation of new cancer drugs for various types of metastatic cancer. Moreover, the escalating cancer rate has resulted in a higher prevalence of metastatic cancers. For example, the Journal of the National Cancer Institute reported in 2022 that the number of individuals in the United States diagnosed with metastatic breast, prostate, lung, colorectal, or bladder cancer or metastatic melanoma is projected to reach 0.69 million cases by 2025. The estimated number of American women dealing with metastatic breast cancer has gone up to 168,000 this year, a rise from 155,000 the previous year. Consequently, the uptick in metastatic cancers incidence propels the metastatic cancer drugs market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11941&type=smp
What Are the Key Trends Driving Metastatic Cancer Drugs Market Growth?
The emergence of product innovations is a significant trend that is gaining traction in the metastatic cancer drugs market. Key players in the market are focusing their efforts on creating groundbreaking drugs to solidify their market position. For example, Roche Pharma, a leading global firm in the domains of biotechnology and pharmaceuticals based in Switzerland, launched a drug for breast cancer treatment in May 2022. The company, well-known for its healthcare innovations, introduced PHESGO - the first of its kind fixed-dose oncology formulation that combines the monoclonal antibodies Perjeta and Herceptin with hyaluronidase, making subcutaneous injection with IV chemotherapy possible. This innovative concept slashes clinic visit duration by a remarkable 90%, vastly improving patient comfort. The CEO of Roche Pharma India, V. Simpson Emmanuel, emphasized that the treatment allows patients to allocate more time to pursuits that bring them joy, thereby positively influencing their overall quality of life.
What Are the Emerging Segments in the Metastatic Cancer Drugs Market?
The metastatic cancer drugs market covered in this report is segmented -
1) By Drug Class: HER2 Inhibitors, Immune Checkpoints Inhibitors, PARP Inhibitors, Kinase Inhibitors, Other Drug Class
2) By Cancer: Breast Cancer, Lung Cancer, Liver Cancer, Hematological Cancer, Brain Cancer, Prostate Cancer, Pancreatic Cancer, Other Cancers
3) By Treatment: Chemotherapy, Immunotherapy, Hormonal Therapy, Surgery, Other Treatments
4) By Route Of Administration: Intravenous, Intramuscular, Oral, Other Routes Of Administration
5) By End-Users: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By HER2 Inhibitors: Trastuzumab, Ado-trastuzumab emtansine, Lapatinib
2) By Immune Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors
3) By PARP Inhibitors: Olaparib, Rucaparib, Niraparib
4) By Kinase Inhibitors: EGFR Inhibitors, BRAF Inhibitors, ALK Inhibitors
5) By Other Drug Classes: Chemotherapy Agents, Hormonal Therapies, Targeted Therapies
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11941&type=smp
Who Are the Global Leaders in the Metastatic Cancer Drugs Market?
Major companies operating in the metastatic cancer drugs market include Pfizer Inc., Johnson and Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Astellas Pharma Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Incyte Corporation, Ipsen SA, Seagen Inc., Exelixis Inc., Zymeworks Inc., Karyopharm Therapeutics Inc., CRISPR Therapeutics AG, Fate Therapeutics Inc., CytomX Therapeutics Inc., Spectrum Pharmaceuticals Inc., Intellia Therapeutics Inc., GlaxoSmithKline plc, Adaptimmune Therapeutics plc
Which are the Top Profitable Regional Markets for the Metastatic Cancer Drugs Industry?
North America was the largest region in the metastatic cancer drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metastatic cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11941
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2025 Metastatic Cancer Drugs Industry Trends Report: Long-Term Outlook Through 2034 here
News-ID: 4180470 • Views: …
More Releases from The Business Research Company
Nano Antibodies Market Overview: Major Segments, Strategic Developments, and Lea …
The nano antibodies market is gaining significant attention due to its promising applications in precision medicine and targeted therapies. With rapid advancements in biotechnology and increasing research efforts, this market is poised for considerable expansion in the coming years. Let's explore the current market valuation, key drivers, leading companies, and emerging trends shaping this dynamic sector.
Projected Growth and Market Size of the Nano Antibodies Market
The nano antibodies market is anticipated…
Emerging Sub-Segments Transforming the Mitotic Spindle Organizing Protein 2B (MZ …
Understanding the growth potential of niche biotechnology markets reveals exciting opportunities for innovation and investment. One such area gaining attention is the mitotic spindle organizing protein 2B (MZT2B) antibody market, which is poised for remarkable expansion due to advances in medical research and technology. Let's explore the current landscape, key players, market segments, and factors driving this market forward.
Projected Growth Trajectory of the Mitotic Spindle Organizing Protein 2B (MZT2B) Antibody…
Top Players and Competitive Dynamics in the Menopause Supplement Market
The menopause supplement market is set for significant expansion in the coming years, driven by evolving healthcare demands and growing awareness of women's wellness. As more individuals seek tailored health solutions, the market is responding with innovative products and services designed to support women during menopause and beyond. Below, we explore the market size, influential players, and emerging trends shaping this industry's future.
Expected Growth Trajectory of the Menopause Supplement Market
The…
In-Depth Examination of Segments, Industry Developments, and Key Players in the …
The market for liquid carbon dioxide storage tanks is set for strong expansion in the coming years, supported by rising sustainability priorities and steady technological advancements across multiple industries. A closer look at the market size, major players, evolving trends, and detailed segmentation provides a clear understanding of the current dynamics and future potential.
Projected Growth and Market Size of Liquid Carbon Dioxide Storage Tanks
The liquid carbon dioxide storage tanks market…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
